Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
Get Adobe Flash player

Pharmaceuticals

Sales rise for Roche's cancer drug Add to ...

11.27 billion Swiss francs ($12.1-billion U.S.) is the third quarter sales figures from Swiss drug maker Roche. The world's biggest maker of cancer drugs is banking on a new generation of breast cancer medicines to drive sales growth. Sonia Legg reports

Drive

Technology